Aetion to collaborate with UK's NICE on RWE; 4D's cystic fibrosis gene therapy cleared for clinical trials
New York-based real world evidence, or RWE, firm Aetion is teaming up with the National Institute for Health and Care Excellence in the United Kingdom to analyze data such as hospital records, prescription records and more to study clinical effectiveness and fill gaps in evidence.
As Aetion CEO Carolyn Magill told Endpoints News, the company’s goal is to collect evidence that would be harder to get outside of a controlled setting, such as a clinical trial.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.